These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33959037)

  • 21. MRI-based cerebrovascular reactivity using transfer function analysis reveals temporal group differences between patients with sickle cell disease and healthy controls.
    Leung J; Duffin J; Fisher JA; Kassner A
    Neuroimage Clin; 2016; 12():624-630. PubMed ID: 27722086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease.
    Václavů L; Meynart BN; Mutsaerts HJMM; Petersen ET; Majoie CBLM; VanBavel ET; Wood JC; Nederveen AJ; Biemond BJ
    Haematologica; 2019 Apr; 104(4):690-699. PubMed ID: 30523051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of Cerebral Blood Flow and Arterial Transit Time From Multi-Delay Arterial Spin Labeling MRI Using a Simulation-Based Supervised Deep Neural Network.
    Ishida S; Isozaki M; Fujiwara Y; Takei N; Kanamoto M; Kimura H; Tsujikawa T
    J Magn Reson Imaging; 2023 May; 57(5):1477-1489. PubMed ID: 36169654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative cerebrovascular reactivity MRI in mice using acetazolamide challenge.
    Wei Z; Li Y; Hou X; Han Z; Xu J; McMahon MT; Duan W; Liu G; Lu H
    Magn Reson Med; 2022 Nov; 88(5):2233-2241. PubMed ID: 35713368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White Matter Cerebrovascular Reactivity: Effects of Microangiopathy and Proximal Occlusions on the Dynamic BOLD Response.
    Gee JM; Wang X; Dogra S; Veraart J; Ishida K; Dehkharghani S
    medRxiv; 2023 Jun; ():. PubMed ID: 37398412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial Transit Time-Based Multidelay Combination Strategy Improves Arterial Spin Labeling Cerebral Blood Flow Measurement Accuracy in Severe Steno-Occlusive Diseases.
    Amemiya S; Watanabe Y; Takei N; Ueyama T; Miyawaki S; Koizumi S; Kato S; Takao H; Abe O; Saito N
    J Magn Reson Imaging; 2022 Jan; 55(1):178-187. PubMed ID: 34263988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in cerebral blood flow and vasoreactivity to CO2 measured by arterial spin labeling after 6days at 4350m.
    Villien M; Bouzat P; Rupp T; Robach P; Lamalle L; Troprès I; Estève F; Krainik A; Lévy P; Warnking JM; Verges S
    Neuroimage; 2013 May; 72():272-9. PubMed ID: 23384523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral hyperperfusion and decreased cerebrovascular reactivity correlate with neurologic disease severity in MELAS.
    Rodan LH; Poublanc J; Fisher JA; Sobczyk O; Wong T; Hlasny E; Mikulis D; Tein I
    Mitochondrion; 2015 May; 22():66-74. PubMed ID: 25801712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Cerebrovascular Reactivity and Cognition Among People With Risk of Cognitive Decline.
    Kim D; Hughes TM; Lipford ME; Craft S; Baker LD; Lockhart SN; Whitlow CT; Okonmah-Obazee SE; Hugenschmidt CE; Bobinski M; Jung Y
    Front Physiol; 2021; 12():645342. PubMed ID: 34135768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.
    Noguchi T; Kawashima M; Nishihara M; Egashira Y; Azama S; Irie H
    Eur J Radiol; 2015 Jun; 84(6):1137-43. PubMed ID: 25816991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial coefficient of variation of arterial spin labeling magnetic resonance imaging can predict decreased cerebrovascular reactivity measured by acetazolamide challenge single-photon emission tomography.
    Taira N; Hara S; Namba A; Tanaka Y; Maehara T
    Neuroradiology; 2024 Oct; 66(10):1693-1703. PubMed ID: 39042167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental trajectories of cerebrovascular reactivity in healthy children and young adults assessed with magnetic resonance imaging.
    Leung J; Kosinski PD; Croal PL; Kassner A
    J Physiol; 2016 May; 594(10):2681-9. PubMed ID: 26847953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease.
    Tsujikawa T; Kimura H; Matsuda T; Fujiwara Y; Isozaki M; Kikuta K; Okazawa H
    PLoS One; 2016; 11(6):e0156005. PubMed ID: 27275779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of a shorter-delay arterial spin labeling protocol for detecting cerebrovascular impairment.
    Zhuang C; Poublanc J; Mcketton L; Venkatraghavan L; Sobczyk O; Duffin J; Crawley AP; Fisher JA; Wu R; Mikulis DJ
    Quant Imaging Med Surg; 2021 Feb; 11(2):608-619. PubMed ID: 33532261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust arterial transit time and cerebral blood flow estimation using combined acquisition of Hadamard-encoded multi-delay and long-labeled long-delay pseudo-continuous arterial spin labeling: a simulation and in vivo study.
    Ishida S; Kimura H; Isozaki M; Takei N; Fujiwara Y; Kanamoto M; Kosaka N; Matsuda T; Kidoya E
    NMR Biomed; 2020 Aug; 33(8):e4319. PubMed ID: 32424992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrovascular Reservoir and Arterial Transit Time Changes Assessed by Acetazolamide-Challenged Multi-Phase Arterial Spin Labeling Perfusion MRI in Chronic Cerebrovascular Steno-Occlusive Disease.
    Hwang I; Sohn CH; Jung KH; Yeon EK; Lee JY; Yoo RE; Kang KM; Yun TJ; Choi SH; Kim JH
    Taehan Yongsang Uihakhoe Chi; 2021 May; 82(3):626-637. PubMed ID: 36238775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.